Stocktoria

Bain Capital Specialty Finance, Inc. BCSF

NYSE · stock · website · IPO 2018-11-15 · LEI

Bain Capital Specialty Finance, Inc. (BCSF) earns a Piotroski F-score of 2/9 (weak financial health). It pays a dividend yielding 18.32% (safety: at-risk).

Chart by TradingView
22/100
Stocktoria Quality Score · grade D
2/9
Piotroski F — financial health
Altman Z″ — distress risk
11.1%
Dividend yield 5y avg · at-risk · Dividend payout 147.7%

Quality score trend · recomputed for each fiscal year

Piotroski F /9
3 6 2 2 2022202320242025

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$12.65 as of 2026-08-01 · -20% 1y
$12.40$15.8252-wk
Market cap USD$796M
P / E8.1×
Dividend yield 5y avg11.1%
Return on equity 5y avg10.1%
Beta0.63

Analyst price target

$13.83 +9.4% vs last
· 3 analysts
target range $13.00 – $15.00

Wall Street analyst consensus — a sentiment gauge, not our scoring.

Piotroski F breakdown · 2/9 tests passed

About Bain Capital Specialty Finance, Inc.

Bain Capital Specialty Finance, Inc. is business development company specializing in direct loans to middle-market companies. The fund seeks to invest in senior investments with a first or second lien on collateral, senior first lien, stretch senior, senior second lien, unitranche, mezzanine debt, junior securities, other junior investments, and secondary purchases of assets or portfolios that primarily consist of middle-market corporate debt. It typically invests in companies with EBITDA between $10 million and $150 million.

FAQ

Is BCSF financially healthy?

Bain Capital Specialty Finance, Inc.'s Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak).

Does BCSF pay a dividend, and is it safe?

Yes. Bain Capital Specialty Finance, Inc. pays a dividend yielding about 18.32% with a 147.7% payout ratio, rated “at-risk” for safety.

How profitable is BCSF?

In FY2025, Bain Capital Specialty Finance, Inc. had a return on equity of 8.8%.

Is BCSF overvalued or undervalued?

Bain Capital Specialty Finance, Inc. trades at about 8.3× trailing earnings — near its 10-year norm (10-year range 8.0×–9.8×, median 8.6×). Stocktoria reports the data, not buy/sell advice.

What is the analyst price target for BCSF?

The average Wall-Street price target for Bain Capital Specialty Finance, Inc. is $13.83, about 9.4% above the recent price, from 3 analysts.

Is BCSF a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on Bain Capital Specialty Finance, Inc.: a Piotroski F-score of 2/9, a P/E of about 8.1×, a dividend yield of 18.32%. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.